ORIC Pharmaceuticals names general counsel

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company, announced Dr. Christian Kuhlen has been named general counsel.

This is members-only content

You are not logged in and your 1 free access to members-only content has been used up.

If you are already a registered user or a member, SIGN IN now.